Jinxin Fertility Group Limited (“JXR”) reported a material capital-base adjustment on 9 April 2026, following the cancellation of repurchased shares and the full elimination of its treasury stock.

JXR cancelled 39.66 million ordinary shares that had been repurchased on 5, 8-12, 15 and 17 December 2025 at a volume-weighted average price of HKD 2.530984 per share. The transaction represents 1.45 % of the company’s issued share capital before the cancellation and implies a total cash consideration of approximately HKD 100.31 million.

Concurrently, the board cancelled the entire 13.00 million shares previously held in treasury.

Combined, the two actions have reduced JXR’s total issued share count from 2.76 billion to 2.71 billion, a net contraction of 52.66 million shares, or 1.91 % of the pre-event total. All treasury shares have now been extinguished, leaving JXR with 2.71 billion ordinary shares in issue and no shares in treasury as at 9 April 2026.

The board confirmed that the repurchase and cancellations complied with all Hong Kong Listing Rules and relevant regulatory requirements.